Jyothy Laboratories spurted 5.62% to Rs 365.80 at 14:24 IST on BSE after a bulk deal of 6 lakh shares was executed on the scrip at Rs 363.75 per share at 10:46 IST on BSE.
Meanwhile, the S&P BSE Sensex was up 61.45 points, or 0.18%, to 33,539.80. The S&P BSE Mid-Cap index was off 42.41 points, or 0.25%, to 16,751.82.
Bulk deal boosted volume on the scrip. On the BSE, so far 6.36 lakh shares were traded in the counter, compared with average daily volumes of 11,044 shares in the past one quarter. The stock hit a high of Rs 369.70 and a low of Rs 350 so far during the day. The stock hit a record high of Rs 441 on 19 September 2017. The stock hit a 52-week low of Rs 322.50 on 27 December 2016.
The stock had underperformed the market over the past 30 days till 21 November 2017, sliding 9.73% compared with 2.99% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 6.96% as against Sensex's 6.05% rise. The scrip also underperformed the market in past one year, rising 2.68% as against Sensex's 28.96% rise.
The mid-cap company has equity capital of Rs 18.18 crore. Face value per share is Re 1.
On a consolidated basis, net profit of Jyothy Laboratories rose 46.93% to Rs 45.71 crore on 4.31% rise in net sales to Rs 429.91 crore in Q2 September 2017 over Q2 September 2016.
Jyothy Laboratories is a fast moving consumer goods company. It is involved in the manufacturing and marketing of products in fabric care, mosquito repellant, surface cleaning and personal care products. The company's power include Ujala, Maxo, Exo, Henko, Pril, and Margo.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
